Literature DB >> 23007325

CD151 promotes cancer cell metastasis via integrins α3β1 and α6β1 in vitro.

Yujie Fei1, Ji Wang, Weifeng Liu, Houjuan Zuo, Jin Qin, Daowen Wang, Hesong Zeng, Zhengxiang Liu.   

Abstract

CD151 is a member of the tetraspanin family that is implicated as a promoter of the tumor metastasis of malignant cells. Tetraspanins form membrane complexes with integrins. In the present study, we constructed a CD151-AAA mutant to assess the roles of Rac, cdc42 and phospho-Rac/cdc42 (P-Rac/cdc42) and the effects of CD151‑integrin complexes on the proliferation, migration and invasion of HepG2 cells. The pAAV-CD151 and pAAV‑CD151‑AAA mutant plasmids were constructed and used to transiently transfect HepG2 cells using the Qiagen Attractene transfection reagent. Following transfection, the expression of CD151 was determined by western blotting. A cell proliferation assay was performed using the cell counting kit-8 (CCK-8) method, cell migration was assessed by a cell wound-healing assay and cell invasion was evaluated in microchemotaxis chambers using FBS as the chemotactic stimulus. The potential involvement of various signaling pathways was explored using relevant antibodies. The association between CD151 and integrins was evaluated by immunoblotting analysis. We found that CD151 promoted cell proliferation, migration and chemotaxis and increased P-Rac/cdc42 activity. The CD151-AAA mutant had reduced cellular proliferation, migration and invasion compared with the CD151 mutant. Moreover, the CD151-AAA mutant abrogated the association between CD151 and integrins. These data suggest that CD151 forms complexes by interacting with integrins, particularly α3β1 and α6β1, and thereby affects the functioning of the HepG2 cells. The mechanism is possibly related to the Rac, cdc42 and P-Rac/cdc42 signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23007325     DOI: 10.3892/mmr.2012.1095

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  15 in total

Review 1.  Tetraspanins in cell migration.

Authors:  Xupin Jiang; Jiaping Zhang; Yuesheng Huang
Journal:  Cell Adh Migr       Date:  2015-06-19       Impact factor: 3.405

Review 2.  Tetraspanin proteins promote multiple cancer stages.

Authors:  Martin E Hemler
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

3.  miR-152 suppresses gastric cancer cell proliferation and motility by targeting CD151.

Authors:  Ronglin Zhai; Xuefeng Kan; Bo Wang; Hansong Du; Yueping Long; Heshui Wu; Kaixiong Tao; Guobin Wang; Lihong Bao; Fen Li; Wanli Zhang
Journal:  Tumour Biol       Date:  2014-08-15

Review 4.  Cancer cells remodel themselves and vasculature to overcome the endothelial barrier.

Authors:  Anitha K Shenoy; Jianrong Lu
Journal:  Cancer Lett       Date:  2014-10-31       Impact factor: 8.679

5.  Expression of cluster of differentiation 151 prior to and following transcatheter arterial chemoembolization therapy in patients with hepatocellular carcinoma and its association with clinicopathological characteristics.

Authors:  Zhen Kang; Enhua Xiao
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

Review 6.  Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.

Authors:  S Detchokul; E D Williams; M W Parker; A G Frauman
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

7.  Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition.

Authors:  Bow J Tauro; Rommel A Mathias; David W Greening; Shashi K Gopal; Hong Ji; Eugene A Kapp; Bradley M Coleman; Andrew F Hill; Ulrike Kusebauch; Janice L Hallows; David Shteynberg; Robert L Moritz; Hong-Jian Zhu; Richard J Simpson
Journal:  Mol Cell Proteomics       Date:  2013-05-03       Impact factor: 5.911

8.  C5aR1 regulates migration of suppressive myeloid cells required for costimulatory blockade-induced murine allograft survival.

Authors:  Ines Llaudo; Miguel Fribourg; M Edward Medof; Patricia Conde; Jordi Ochando; Peter S Heeger
Journal:  Am J Transplant       Date:  2018-09-17       Impact factor: 8.086

Review 9.  CD151-A Striking Marker for Cancer Therapy.

Authors:  Seema Kumari; Gayatri Devi; Anil Badana; Venkata Ramesh Dasari; Rama Rao Malla
Journal:  Biomark Cancer       Date:  2015-03-22

10.  CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.

Authors:  Jianjie Zhu; Tingting Cai; Jieqi Zhou; Wenwen Du; Yuanyuan Zeng; Ting Liu; Yulong Fu; Yue Li; Qian Qian; Xiuwei H Yang; Qinglin Li; Jian-An Huang; Zeyi Liu
Journal:  J Exp Clin Cancer Res       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.